Small Cell Lung Cancer Expressing Glutamate Decarboxylase with Latent Autoimmune Diabetes in Adults

Takanori Asakura; Shuichi Yoshida; Arafumi Maeshima; Kazuyuki Fujimoto; Rie Jo; Kyoko Iwase; Yoshitaka Oyamada

doi:10.2169/internalmedicine.54.4478

CASE REPORTS

Small Cell Lung Cancer Expressing Glutamate Decarboxylase with Latent Autoimmune Diabetes in Adults

Takanori Asakura, Shuichi Yoshida, Arafumi Maeshima, Kazuyuki Fujimoto, Rie Jo, Kyoko Iwase, Yoshitaka Oyamada

著者情報

キーワード: small cell lung cancer, glutamate decarboxylase, diabetes mellitus, paraneoplastic syndrome, latent autoimmune diabetes in adults

ジャーナルオープンアクセス

2015 年 54 巻 23 号 p. 3035-3037

DOI https://doi.org/10.2169/internalmedicine.54.4478

詳細

抄録

Small cell lung cancer (SCLC) causes paraneoplastic syndromes, such as diabetes mellitus, by eliciting the expression of various antibodies including anti-glutamate decarboxylase (GAD) antibody. A 62-year-old woman presented to our hospital with a 1-week history of progressive dyspnea and difficulty in walking. Computed tomography showed a tumor obstructing the left bronchus and obstructive lung abscesses with pleural effusions. A biopsy during bronchoscopy revealed SCLC, and the clinical stage was ultimately determined to be IIIB. SCLC was complicated by diabetes mellitus with high titers of serum anti-GAD antibody. An immunohistochemical analysis showed GAD expression in the cancer cells, which is a novel finding.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）